Prolysis
-
Biota Acquires Antibacterial Assets of Prolysis
Biota Holdings has announced the acquisition of the key assets and programs of Prolysis, an antibacterial drug discovery company located in Oxford, England. Prolysis has two primary projects that are focused on new antibiotics for multiple drug r…
Prolysis | 26 November 2009
